Study Demonstrates Feasibility of Migraine-Specific CBT

Researchers in Germany showed that targeted behavioral therapies may benefit patients with migraine. Katherine Hamilton, MD, of the University of Pennsylvania, weighs-in on the results of the research. A new study published in Headache: The Journal of Head and Face Pain® demonstrated the feasibility of developing a cognitive behavioral therapy program specifically for migraine patients, according to Katherine Hamilton, MD, of the University of Pennsylvania. “It’s a first step to ultimately figuring out whether this is something that’s effective and can be incorporated into headache practice,” says Dr. Hamilton, who was not affiliated with the research. Hamilton notes that some...

New Data on Efficacy of Mindfulness-Based Interventions in Migraine to be Shared at AHS 61st Annual Scientific Meeting

AHS POV: “We know migraine has an impact on everyday life beyond the pain associated with migraine itself. People with migraine often hold back from attending social functions and traveling when the onset of migraine is beginning, or feel frustrated, angry and isolated. These study results can help healthcare providers and patients as they evaluate additional, non-traditional treatment options for migraine,” said American Headache Society President Kathleen Digre. At the American Headache Society (AHS) 61st Annual Scientific Meeting, researchers are presenting data looking at the impact of mindfulness-based cognitive therapy (MBCT) on migraine-related disability. Mindfulness-based interventions have been shown to...

New Research on Opioid Use in Migraine Reveals Challenges of Acute Migraine Care as Revealed in Studies to be Presented at AHS 61st Annual Scientific Meeting

New Research on Opioid Use in Migraine Reveals Challenges of Acute Migraine Care as Revealed in Studies to be Presented at The American Headache Society 61st Annual Scientific Meeting AHS POV: “As new treatment options designed specifically to prevent and treat the often excruciating pain and associated symptoms of migraine, the number of patients requiring pain relief through opioids will likely decrease. Physicians and patients must work together to identify the most appropriate treatment plan tailored to each patient for managing this chronic and often debilitating health condition,” said Andy Charles, Chair of the Scientific Program Committee. Three observational studies...

The Maternal Migraine Link to Babies with Colic to be Unveiled at The American Headache Society 61st Annual Meeting

AHS POV: “While more research is needed, this new study suggests healthcare providers should talk to parents about the increased possibility of colic in a baby whose mother has a history of migraine, as well as provide extra resources, education and support to these families at an early stage,” said Andy Charles, Chair of the Scientific Program Committee A leading pediatric headache expert will present data at the American Headache Society (AHS) 61st Annual Scientific Meeting that identifies a connection between mothers with migraine and babies with colic, or excessive crying in an otherwise healthy infant. The study, “The Association...

Global Leaders in Migraine Research to Convene at The American Headache Society 61st Annual Scientific Meeting

Emerging Data Advances Understanding of Migraine Impact and Treatment MOUNT ROYAL, N.J., June 25, 2019 /PRNewswire/ – At the American Headache Society (AHS) 61st Annual Scientific Meeting, leading researchers and clinicians specializing in migraine, cluster headache, post-traumatic headache, and other types of headache will present groundbreaking data on the basic and clinical science of these extraordinarily common and disabling diseases. Exciting advances in the treatment of migraine and cluster headache will be highlighted at the meeting, which takes place July 11 – July 14, 2019 in Philadelphia, Pennsylvania. Dr. Andrew Charles, the Chair of the Scientific Program Committee for the...

Adverse Pregnancy Risks Linked to Migraine in Women

The impact of migraine treatment not associated with pregnancy complications, but further research needed, expert says Women with migraine and their offspring are at greater risk for adverse pregnancy outcomes, compared with women without migraine, according to a study published in Headache: The Journal of Head and Face Pain®. Stanford Medicine’s Nada Hindiyeh, MD, says the research offers a look at some aspects of migraine and pregnancy that have not yet been explored. “What’s new in this study, which hadn’t really been looked at before, was the finding that maternal migraine may increase the risk of several neonatal and neurological...

Vagus Nerve Stimulation for Migraine and Cluster Headache

This non-invasive, FDA-cleared treatment option decreases the likelihood of headaches Recent clinical trials have been evaluating vagus nerve stimulation (VNS) for the treatment of various headache conditions, including migraine and cluster headache. In November 2018, the FDA cleared the VNS device for treatment of cluster headache. Dr. Katherine Hamilton, a neurologist and assistant professor of clinical neurology at the University of Pennsylvania, weighed in on how VNS can help patients manage migraine and cluster headache. https://www.youtube.com/watch?v=S3WXsz8Zsjg What conditions does VNS treat? In the spring of 2018, VNS was FDA-cleared as an acute or abortive treatment for migraine. The trial evidence...

Maintaining Compassion on Diet-Based Migraine Matters

Alan Finkel, MD, FAHS, highlights the need to listen to and support patients with migraine who may be struggling with diet or weight issues Alan Finkel, MD, FAHS, spoke at the 2018 Scottsdale Headache Symposium about how healthcare providers should address diet in relation to migraine treatment. Watch the full interview here: https://www.youtube.com/watch?v=Mwj326YYG9s It is imperative for healthcare providers to speak honestly with their patients about diet and food triggers, which can be difficult to address in migraine treatment. Changes are ultimately up to the patient, but doctors cannot forget that they need to listen to what patients are saying...

How Doctors Determine Acute Migraine Treatment Plans: Q&A with Stewart Tepper, MD, FAHS

Dr. Tepper walks through what needs to be considered when determining how to treat a patient’s migraine attacks Patients with migraine are all different individuals, and this needs to be reflected in their treatment plans. AHS board member Stewart Tepper, MD, FAHS, professor of neurology at the Geisel School of Medicine at Dartmouth and the director of the Dartmouth Headache Center at Dartmouth Hitchcock Medical Center in the Department of Neurology, recently spoke with us about how to determine the best way forward. What details of a patient’s medical history should a headache specialist consider when creating an acute migraine...

Recent Developments in Migraine and Cluster Headache Treatment

Anti-CGRP self-injection approved for episodic cluster headache, neuromodulation device cleared for acute treatment of migraine Galcanezumab for treatment of episodic cluster headache in adults On June 4, 2019, the FDA approved galcanezumab-gnlm (Emgality®) for the treatment of episodic cluster headache in adults. This self-injection treatment was first approved by the FDA in September 2018 for the preventive treatment of migraine in adults. In a clinical trial, patients receiving monthly injections of galcanezumab experienced 8.7 fewer weekly cluster headache attacks, compared to 5.2 fewer attacks for patients on placebo. The trial measured the average number of cluster headaches per week for...